Pharmafile Logo

COUCH Medcomms

- PMLiVE

China weighs heavy on GSK figures in Q3

Pharma company loses two thirds of sales in region after scandal-hit period

- PMLiVE

Celgene’s Revlimid knocked-back by NICE

Final draft guidance from NICE does not recommend drug for rare bone marrow disorder

- PMLiVE

Priority review for Lilly’s ramucirumab in gastric cancer

Update comes as company posts improved revenue results

- PMLiVE

Senior banker joins Lilly’s board

Jackson Tai is former CEO of the Asian financial firm DBS

- PMLiVE

Publicis Groupe adds to Indian portfolio

Comms group acquires Beehive Communications

- PMLiVE

UK PR body bids to stop theft of pitch ideas

Public Relations Consultants Association plans to help agencies safeguard their intellectual property

- PMLiVE

It’s time for growth

Time for pharma marketers to get back to what they do best

- PMLiVE

New head at Cardiovascular Research Foundation

Jack Lewin is former CEO of American College of Cardiology and the California Medical Association

- PMLiVE

Roche signs biologics partnership with Samsung

Manufacturing deal follows investment in pharma firm's own capabilities

- PMLiVE

Amgen buys total filgrastim rights from Roche

Wrests control of white blood cell stimulator franchise

Novartis building

NICE backs Novartis/ ThromboGenics’ eye drug

Recommends Jetrea for NHS use in England and Wales to treat the rare disease vitreomacular traction

- PMLiVE

EMA defends position on patient-level data

Regulator claims pharma industry fears over transparency are unfounded

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links